
Encoded Therapeutics – Translating Next-Generation Science into ...
Translating Next-Generation Science Into Transformative Gene TherapiesLearn About Our Programs
Our Science – Encoded Therapeutics
Ever wondered what it takes to make a gene therapy? Join us on a virtual lab tour at Encoded’s headquarters in South San Francisco. Meet a few of our talented scientists ready to explain …
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data …
Dec 1, 2025 · Encoded Therapeutics is a clinical-stage genetic medicines company developing one-time therapies for severe neurological disorders. Our vector engineering platform enables …
News – Encoded Therapeutics
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society …
Programs – Encoded Therapeutics
Programs Encoded is building an internally developed pipeline of best- and potentially first-in-class therapies focused on neurological disorders.
About – Encoded Therapeutics
Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Our diversity – whether gender, ethnicity, sexual …
Careers – Encoded Therapeutics
Encoded offers competitive pay, an equity program and benefits. We provide the support that team members need at work to succeed, and we give back the benefits and perks to maintain …
Encoded Therapeutics Presents Preclinical Data Across its Gene …
Encoded Therapeutics is a clinical-stage genetic medicines company developing potentially disease-modifying therapies to improve the lives of people with severe CNS disorders.
Encoded Therapeutics Announces US IND Clearance and …
Encoded will be providing additional updates on its research pipeline, which is focused on both rare genetic and common disease programs, in addition to clinical progress with ETX101 for …
Encoded Therapeutics Announces Regenerative Medicine …
Encoded Therapeutics is a clinical-stage genetic medicines company developing potentially one-time, disease-modifying therapies for severe neurological disorders.